The prevalence of extramedullary acute myeloid leukemia detected by (18)FDG-PET/CT: final results from the prospective PETAML trial

Extramedullary (EM) disease in patients with acute myeloid leukemia (AML) is a known phenomenon. Since the prevalence of EM AML has so far only been clinically determined on examination, we performed a prospective study in patients with AML. The aim of the study was to determine the prevalence of me...

Descripción completa

Detalles Bibliográficos
Autores principales: Stölzel, Friedrich, Lüer, Tors, Löck, Steffen, Parmentier, Stefani, Kuithan, Friederike, Kramer, Michael, Alakel, Nael S., Sockel, Katja, Taube, Franziska, Middeke, Jan M., Schetelig, Johannes, Röllig, Christoph, Paulus, Tobias, Kotzerke, Jörg, Ehninger, Gerhard, Bornhäuser, Martin, Schaich, Markus, Zoephel, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271590/
https://www.ncbi.nlm.nih.gov/pubmed/31467130
http://dx.doi.org/10.3324/haematol.2019.223032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271590/
https://www.ncbi.nlm.nih.gov/pubmed/31467130
http://dx.doi.org/10.3324/haematol.2019.223032

Ejemplares similares